165 related articles for article (PubMed ID: 35757136)
1. Morning Versus Evening Dosing of Sublingual Immunotherapy in Allergic Asthma: A Prospective Study.
Liao F; Chen S; Wang L; Quan YY; Chen LL; Lin GH
Front Pediatr; 2022; 10():892572. PubMed ID: 35757136
[TBL] [Abstract][Full Text] [Related]
2. Association between biomarkers and house dust mite sublingual immunotherapy in allergic asthma.
Hoshino M; Akitsu K; Kubota K; Ohtawa J
Clin Exp Allergy; 2020 Sep; 50(9):1035-1043. PubMed ID: 32557974
[TBL] [Abstract][Full Text] [Related]
3. Clinical Evaluation for Sublingual Immunotherapy With
Zhang AZ; Liang ME; Chen XX; Wang YF; Ma K; Lin Z; Xue KK; Cao LR; Yang R; Zhang HP
Front Med (Lausanne); 2021; 8():645356. PubMed ID: 34422846
[No Abstract] [Full Text] [Related]
4. Clinical evaluation for sublingual immunotherapy with Dermatophagoides farinae drops in adult patients with allergic asthma.
Zhong C; Yang W; Li Y; Zou L; Deng Z; Liu M; Huang X
Ir J Med Sci; 2018 May; 187(2):441-446. PubMed ID: 29032417
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of house dust mite sublingual immunotherapy on clinical and pulmonary function in patients with asthma and allergic rhinitis.
Hoshino M; Akitsu K; Ohtawa J; Kubota K
J Allergy Clin Immunol Glob; 2024 May; 3(2):100206. PubMed ID: 38328802
[TBL] [Abstract][Full Text] [Related]
6. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
7. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
8. Effect of Sublingual Immunotherapy on Airway Inflammation and Airway Wall Thickness in Allergic Asthma.
Hoshino M; Akitsu K; Kubota K
J Allergy Clin Immunol Pract; 2019; 7(8):2804-2811. PubMed ID: 31228618
[TBL] [Abstract][Full Text] [Related]
9. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation for sublingual immunotherapy of allergic asthma and atopic rhinitis with Dermatophagoides Farinae Drops].
Cao LF; Lu Q; Gu HL; Chen YP; Zhang Y; Lu M; Qian YQ; Li L; Xu YP
Zhonghua Er Ke Za Zhi; 2007 Oct; 45(10):736-41. PubMed ID: 18211754
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and economic evaluation of sublingual immunotherapy with Dermatophagoides farinae drops in patients with allergic rhinitis and allergic asthma].
Wang MS; Wu HT; Huang XB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):538-542. PubMed ID: 29871064
[No Abstract] [Full Text] [Related]
12. The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.
Emminger W; Hernández MD; Cardona V; Smeenk F; Fogh BS; Calderon MA; de Blay F; Backer V
Int Arch Allergy Immunol; 2017; 174(1):35-44. PubMed ID: 28950268
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of sublingual immunotherapy with Dermatophagoides farinae drops in preschool and school-age children with allergic asthma and allergic rhinitis].
Chen S; Wang L; Liao F; Zeng X; Xing QB; Chen B; Lin XZ
Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):831-5. PubMed ID: 24484557
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy of sublingual specific immunotherapy in children with allergic rhinitis].
Li P; Fa M; Huang ZH; Xie LS; Xu Y; Chen WB; Zhang JY; Zhang XR; Zhu Z; Li Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):546-551. PubMed ID: 29871066
[No Abstract] [Full Text] [Related]
16. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Efficacy of Sublingual Mite Immunotherapy in Monosensitized and Polysensitized Children with Allergic Rhinitis: A 7-Year Prospective Study.
Cui L; Li J; Li Y; Xia Z
Int Arch Allergy Immunol; 2019; 180(2):144-149. PubMed ID: 31256165
[TBL] [Abstract][Full Text] [Related]
18. Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites.
Maloney J; Prenner BM; Bernstein DI; Lu S; Gawchik S; Berman G; Kaur A; Li Z; Nolte H
Ann Allergy Asthma Immunol; 2016 Jan; 116(1):59-65. PubMed ID: 26553448
[TBL] [Abstract][Full Text] [Related]
19. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study.
Bahçeciler NN; Işik U; Barlan IB; Başaran MM
Pediatr Pulmonol; 2001 Jul; 32(1):49-55. PubMed ID: 11416876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
